ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3059

Abnormal Body Composition in Takayasu Arteritis Patients: Role of Inflammatory Cytokines and Adipokines

Thiago Ferreira da Silva, Mauricio Levy Neto, Valéria Caparbo, Liliam Takayama and Rosa M R Pereira, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Adipokines, cytokines, DXA, takayasu arteritis and vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Vasculitis Poster III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Chronic inflammatory conditions including rheumatic diseases may alter body composition, especially lean and fat mass. In this process, adipokines and inflammatory cytokines appear to play a key role. The aim of this study is to evaluate the body composition (BC) of TA patients compared to healthy controls (HC), and correlate BC parameters of TA patients with serum adipokines (adiponectin and resistin) and inflammatory cytokines (IL-1a, IL-6 and TNF-α).

Methods: A cross-sectional study was conducted in 45 consecutive women with TA and 47 HC matched by age and body mass index (BMI). BC was measured using dual-energy X-ray absorptiometry (DXA). The fat mass parameters evaluated were: total fat mass (FM), adiposity (percentage of body fat), android and gynoid fat, visceral adipose tissue (VAT) and fat distribution ratio (FDR: FM of the trunk/(FM of arms + FM of legs). Overfat was defined to denote excess body fatness, according to the stratification by age, BMI and ethnicity. Regarding lean mass parameters, total lean mass (LM) and appendicular lean mass index (ALMI: appendicular lean mass/ht2) were analyzed. Abnormal body composition was defined in the presence of overfat (excess body fatness from DXA), low lean mass (ALMI ≤ 5.45 kg/m2) or combination of these two variables. Serum adipokines (adiponectin, resistin) and plasmatic cytokines (IL-1a, IL-6 e TNF-α) were determined by Luminex xMAP Technology.

Results: Abnormal body composition (35.56% vs. 6.38%; p<0.001) was more prevalent in TA patients. Adiposity (%) and android fat mass were higher in TA patients compared to HC (33.05 ± 5.39 vs. 30.43 ± 5.63 %; p=0.025 and 1.58 ± 0.73 vs. 1.27 ± 0.62 Kg; p=0.05). Decreased lean mass (ALMI) was more prevalent in TA patients than HC (24.44% vs. 4.25%; p=0.013). LM had negative correlation with IL-6 levels (r=-0.44; p=0.005). ALMI presented negative correlation with erythrocyte sedimentation rate (ESR) (r=-0.36, p=0.017), resistin (r=-0.34, p=0.035), IL-1a (r=-0.44, p=0.006) and IL-6 (r=-0.43, p=0.007) levels. Fat distribution ratio (FDR) and VAT had negative correlation with adiponectin levels (r=-0.44; p=0.004; r=-0.42; p=0.010). (table 1). Cumulative prednisone dose was not shown any correlations with fat mass or lean mass parameters.

TABLE 1 – Correlations of body composition variables by DXA and inflammatory parameters  in TA patients

 

Lean Mass

ALMI

Fat Mass

FDR

VAT

Android Fat

 

r

p

r

p

r

p

r

p

r

p

r

p

Age

0.09

0.535

0.16

0.286

0.07

0.647

0.18

0.220

0.38

0.019

0.14

0.407

Disease duration

0.02

0.872

0.11

0.469

0.01

0.936

0.02

0.890

-0.02

0.887

-0.01

0.970

Cumulative prednisone

0.02

0.888

-0.05

0.731

0.01

0.945

-0.09

0.562

-0.13

0.664

-0.04

0.879

ESR

-0.20

0.178

-0.36

0.017

0.12

0.406

0.26

0.080

0.17

0.303

0.18

0.288

CRP

0.01

0.946

-0.10

0.494

0.10

0.504

0.19

0.210

0.18

0.277

0.02

0.892

Adiponectin

-0.14

0.369

-0.28

0.084

-0.01

0.933

-0.44

0.004

-0.42

0.010

-0.19

0.260

Resistin

-0.23

0.140

-0.34

0.035

0.05

0.747

0.22

0.161

-0.13

0.425

-0.05

0.766

IL-1a

-0.29

0.077

-0.44

0.006

-0,25

0.123

-0.16

0.331

-0.21

0.207

-0.20

0.225

IL-6

-0.44

0.005

-0.43

0.007

-0.26

0.113

-0.06

0.692

-0.15

0.351

-0.19

0.243

TNF-α

-0.23

0.159

-0.20

0.226

-0.25

0.115

-0.07

0.668

-0.11

0.490

-0.25

0.124

Conclusion: Abnormal BC was significantly more prevalent among TA patients compared to healthy women. Appendicular lean mass was negatively correlated with inflammation parameters and visceral adipose tissue with adiponectin serum levels, suggesting a role of inflammation on the parameters of body composition in women with TA.


Disclosure: T. Ferreira da Silva, None; M. Levy Neto, None; V. Caparbo, None; L. Takayama, None; R. M. R. Pereira, None, 2.

To cite this abstract in AMA style:

Ferreira da Silva T, Levy Neto M, Caparbo V, Takayama L, Pereira RMR. Abnormal Body Composition in Takayasu Arteritis Patients: Role of Inflammatory Cytokines and Adipokines [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/abnormal-body-composition-in-takayasu-arteritis-patients-role-of-inflammatory-cytokines-and-adipokines/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/abnormal-body-composition-in-takayasu-arteritis-patients-role-of-inflammatory-cytokines-and-adipokines/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology